Fountain Healthcare Partners | Activity | F4

Team Portfolio Raise Essays

F4/Fountain Healthcare Partners/Activity

Fountain Healthcare Partners Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Milestone

Neuromod's Lenire was added to U.S. ENT clinical practice guidelines for tinnitus.

Neuromod Devices

Neuromod Devices Fountain Healthcare Partners

fh-partners.comOCT 16, 2026

OCT 16, 2026

Investment

Altay Therapeutics closed a $37M Series A to advance the first oral DUX4 inhibitor for FSHD into the clinic.

Altay Therapeutics

Altay Therapeutics Fountain Healthcare Partners

fh-partners.comOCT 14, 2026

OCT 14, 2026

Investment

MMI raised a $125M Series D to grow commercial sales of the Symani Surgical System.

Medical Microinstruments

Medical Microinstruments Fountain Healthcare Partners

fh-partners.comOCT 8, 2026

OCT 8, 2026

Milestone

MMI's Symani Surgical System treated the first Alzheimer's patient in the REMIND study.

Medical Microinstruments

Medical Microinstruments Fountain Healthcare Partners

fh-partners.comMAY 6, 2026

MAY 6, 2026

Milestone

XyloCor appointed John Tucker as President and CEO.

XyloCor Therapeutics

XyloCor Therapeutics Fountain Healthcare Partners

fh-partners.comMAR 5, 2026

MAR 5, 2026

Investment

Neurent Medical raised 62.5M euros in an oversubscribed Series C.

Neurent Medical

Neurent Medical Fountain Healthcare Partners

fh-partners.comFEB 11, 2026

FEB 11, 2026

Investment

Exciva raised 51M euros ($59M) in a Series B, extended in April 2026.

Exciva

Exciva Fountain Healthcare Partners

fh-partners.comJAN 20, 2026

fh-partners.com

JAN 20, 2026

Exit

Portfolio company Vivasure Medical was acquired by Haemonetics for up to 185M euros.

Vivasure Medical

Vivasure Medical Fountain Healthcare Partners

fh-partners.comJAN 9, 2026

JAN 9, 2026